Stephana Eilene Patton
CIK 1698237 · Chief Legal Officer · last filed 2025-02-21
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
3
Total Filings
14
Lifetime Open-Market Net
$30.4K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CUTERA INC (CUTR) Delisted | Chief Legal Officer | 77,216 | $0.10 | $7.5K | $0 | 6 | 2025-02-21 |
| Eiger BioPharmaceuticals, Inc. (EIGR) Delisted | See Remarks | 17,948 | $1.73 | $31.0K | $11.0K | 4 | 2021-03-15 |
| Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | General Counsel & Secretary | 7,500 | — | — | $19.4K | 2 | 2018-03-19 |
Recent Filings · Page 2 of 2
14 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-12-20 | — | Mixed | +17,990 | -$9.8K | |
| 2018-10-09 | — | Mixed | +8,995 | -$10.6K | |
| 2018-03-19 | Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-08-22 | Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | Buy (P) | +7,500 | $19.4K | EDGAR |
Showing 11–14 of 14
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.